Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. - Wikidata - thesis-toulmin - TriplyDB

Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

http://www.wikidata.org/entity/Q34132926

about

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies An integrative view on sex differences in brain tumors Spinal cord tumours: advances in genetics and their implications for treatment Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification Clinically Relevant Molecular Subtypes in Leiomyosarcoma Gingival tissue transcriptomes identify distinct periodontitis phenotypes.NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma Anaplastic ependymoma of the third ventricle.A prognostic gene expression signature in infratentorial ependymoma.Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.Epigenomic alterations define lethal CIMP-positive ependymomas of infancy Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.Supratentorial ependymoma presenting as a cortical cyst with a mural nodule in an adult.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.The ependymal region of the adult human spinal cord differs from other species and shows ependymoma-like features Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype.Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas.Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.Molecular markers in pediatric neuro-oncology.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.Laminin alpha 2 enables glioblastoma stem cell growth The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.Biology and management of ependymomas.Exomic sequencing of four rare central nervous system tumor types Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

P2860

Q26741529-839614E7-9A82-48E4-95D2-7E711A4E66A0 Q26766642-B7758D6C-2018-49CB-B88D-66DDB41C7502 Q26820289-7488DC32-67EE-4B12-A75B-84A91875FB62 Q26829861-B3C3DBAB-6242-47C7-BC58-2F19AB7C3545 Q26851596-56BF570A-87F1-4DF4-B9E9-4DD955D81E48 Q28383205-CBFDD7A7-1C6D-4BB5-B249-3BCC75B6FC01 Q30300155-EBC07B86-8B27-4A27-891C-4FDD98F9C031 Q30576222-FC8F5EAC-023D-4E85-A491-6F76492A15AA Q30625458-5EA2AC02-0AE6-4019-9397-7A4FC4766251 Q30780517-D0949A09-A738-444F-A177-1B395C128E4C Q33581494-8F4F7751-0752-4944-AE24-393943662E9D Q33634701-ACAD5205-69FC-46CC-A589-E22A2078A0AF Q33730977-B415FA69-DA1E-489C-9808-5B4306F54B07 Q33803137-EC820D31-D297-44F5-A243-5D9D3D6139DF Q33894470-D3FB6A72-C19F-44FC-90EE-4C1E2D1A2FD6 Q34240198-F6B75091-AA75-4AAE-BFC0-8E5D49C452F9 Q34285237-51569979-29E5-4CDC-A77C-287B9E0198DA Q34958194-2DD191A1-7D97-456F-8949-D55211167A95 Q34976095-6EBE5A96-88C0-4676-B9DD-ABF05B983BC3 Q35246513-B7BB380F-48BC-4099-84A0-4DED69D33904 Q35450056-DECE4D78-B3F9-464D-AB1E-1E51B70C9AC0 Q35604841-BF9EA534-1645-47B1-8DCE-A9515F0564A0 Q35674241-ED48D7F4-9F70-4E14-9A5B-770D402CEB31 Q35754390-3C2E4596-9C9F-4215-BDE5-BE975428D6AE Q35860191-67E99BC9-8FF6-4CB0-BE2B-3CC80E50EB4F Q35958168-D8CA4A17-07C0-4434-A6BB-141D9504C497 Q36070798-1ABFBCD9-2530-437A-8D05-E86D2AF3AAD9 Q36082481-DD8CFF29-9E1F-4B43-93CB-2F51538AA10C Q36087220-4B2838A6-573F-4AE5-B6C1-99A6B5C6B426 Q36132647-E92A3D71-4C89-4CA4-965A-A6CF34BDE116 Q36135966-9DEF5ED4-8B65-45FE-BC6A-0EC43E6851A4 Q36344704-26194A4C-678E-4DA3-A752-3D8B64FF819C Q36461766-619A38FA-FFDE-4030-A0F4-E81642B2679A Q36560149-3CA586CE-98BF-4932-86BD-022DD326E6CC Q36737141-52D5BE4A-7825-4B2B-B559-440CFBC00A1B Q36753692-390E7B5E-11BA-41A7-AFCF-EFD1A86D16DF Q36892843-684F432C-BA5D-4C0A-A4AC-8E011380FC48 Q36977704-4B14D528-44CA-4163-892A-44113B4B4A69 Q37038397-A3A50801-9504-42F1-BB94-6E1E6F9B481E Q37130238-0476A715-C619-4B9F-8AAF-2B0BB77FF223

P2860

Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

http://www.wikidata.org/entity/Q34132926

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Delineation of two clinically ...... of posterior fossa ependymoma.

@ast

Delineation of two clinically ...... of posterior fossa ependymoma.

@en

Delineation of two clinically ...... of posterior fossa ependymoma.

@nl

type

label

Delineation of two clinically ...... of posterior fossa ependymoma.

@ast

Delineation of two clinically ...... of posterior fossa ependymoma.

@en

Delineation of two clinically ...... of posterior fossa ependymoma.

@nl

prefLabel

Delineation of two clinically ...... of posterior fossa ependymoma.

@ast

Delineation of two clinically ...... of posterior fossa ependymoma.

@en

Delineation of two clinically ...... of posterior fossa ependymoma.

@nl

P1433

Q34132926-F3B996BA-667A-499E-8DB5-8BCD5D04A1FE

P1476

Q34132926-0363DBAA-3286-4050-9EAF-758D794AFD2A

P2093

Q34132926-00B420D5-A7BD-4A16-9F8E-E9E0DCE6DEC7

Q34132926-119DD6E6-506C-49FC-A6B5-A6A9C52DA407

Q34132926-18C589AA-1F6D-44B3-A027-602246E5A03D

Q34132926-29D98ED9-F658-40FF-A6FE-D79F5EE68DBA

Q34132926-2E65B3FE-BC6C-4864-B013-07AEC2E22737

Q34132926-3950F87B-331F-4D16-9B3E-3F3FC0A71D0F

Q34132926-4660463E-0DB1-444D-8699-A908A8CD34E2

Q34132926-678240DD-0464-4178-AA45-AC6DFC456D37

Q34132926-7A2F642D-C19E-4A82-9533-6DEB9E33A47D

Q34132926-7BAA0FDD-350B-46E4-B4B4-19CC830EF571

P2860

Q34132926-08D1790E-C158-4ECB-9E09-A55D7CB505AB

Q34132926-0E870DDC-06FB-4156-B727-41EB6D2C57B5

Q34132926-15139ABC-D373-402D-92A5-95639071DB40

Q34132926-1764E363-FFD9-4B74-B552-C2C716DEF8FF

Q34132926-1DF1E8DB-C7FF-4FCA-960B-5FACDFC1B21B

Q34132926-201BB44C-B7BF-40C1-A81A-B10CC8AB74AB

Q34132926-29E18456-D4A9-4F43-9D77-C62153311ED6

Q34132926-30D929BA-F079-4CEC-BDB0-4CD1601844F0

Q34132926-35E1E7C1-FADC-4E33-B83E-0BD7D788A3B5

Q34132926-38C08077-ECCD-4C42-8B30-20F932E404A8

P304

Q34132926-83642536-23DA-4A23-BBC0-CE2F2E3DA851

P31

Q34132926-3A77D384-7724-4EC0-9623-7525D3DF9A28

P356

Q34132926-03AB82A6-0D23-4F13-ABD9-E2372BB7533B

P433

Q34132926-95319EA5-A510-42DC-B837-1BB8DCF01CA5

P478

Q34132926-79B9B438-9DA7-486E-AF5F-11F89A7667F2

P50

Q34132926-1CAF4004-E000-49A8-B973-BA64152AE6D9

Q34132926-2B7DCEDE-1D3D-4045-9B67-BBA8915B715A

Q34132926-2E0902B8-5984-4460-AD94-B7513EBEF341

Q34132926-36FC12C0-1D91-449E-806D-46D29A3444B5

Q34132926-43F154E1-3F8D-4F3E-A8D1-A1FF14E2AAE5

Q34132926-60189DE4-60F1-47B4-A6EA-37931CC4B9B4

Q34132926-692E0C59-A213-4D2B-AAF3-FF6C5D858E45

Q34132926-96761661-691E-417B-AA5D-3121AD36A124

Q34132926-E8EEADD6-7E47-408A-B483-A15338151F25

Q34132926-F3191365-4AC1-448C-A16F-A64F832C854A

P577

Q34132926-0F49EE7E-4C36-4459-B8B7-F17D184CD2B4

P5875

Q34132926-3D4EE613-CB0E-44F4-B137-ADFEA175D727

P698

Q34132926-FE7CD3E0-8B84-4D98-B05A-C659F8653F2E

P932

Q34132926-E20CD3A7-237E-4A1D-9CDD-E7BCC56D54A8

P356

J.CCR.2011.07.007

P1433

P1476

Delineation of two clinically ...... of posterior fossa ependymoma.

@en

P2093

Abhijit Guha

http://www.w3.org/2001/XMLSchema#string

Andrea Wittmann

http://www.w3.org/2001/XMLSchema#string

Andreas E Kulozik

http://www.w3.org/2001/XMLSchema#string

Andrey Korshunov

http://www.w3.org/2001/XMLSchema#string

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Boleslaw Lach

http://www.w3.org/2001/XMLSchema#string

Cynthia E Hawkins

http://www.w3.org/2001/XMLSchema#string

David T W Jones

http://www.w3.org/2001/XMLSchema#string

Hendrik Witt

http://www.w3.org/2001/XMLSchema#string

James T Rutka

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas

The 2007 WHO classification of tumours of the central nervous system

Subtypes of medulloblastoma have distinct developmental origins

GenePattern 2.0

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

P304

143-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2011.07.007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

William A Weiss

Stefan M Pfister

Andreas von Deimling

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51570378

http://www.w3.org/2001/XMLSchema#string

P698

21840481

http://www.w3.org/2001/XMLSchema#string

P932

4154494

http://www.w3.org/2001/XMLSchema#string